MarketPeel
Insider Trading Intelligence
FH

Frank A. Holler

XENE
DIRECTOR · XENON PHARMACEUTICALS INC. · CIK 0000938801
FILING MIX · LIFETIME36%/64%
BUYS
4
SELLS
7
TOTAL VALUE
$485.9K
COMPANIES
1
ACTIVE SINCE
May 2020
HOLDINGS NOW
0
AVG SELL PX
$18.75
TRADE KIND
SHOWING 11 / 11
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Frank A. Holler, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+100.00%-1.85%-0.12%-1.73%-1.73%
14d2+0.00%+0.48%+1.03%-0.55%-0.55%
30d2+100.00%-1.69%+2.08%-3.77%-3.77%
60d2+100.00%-5.18%+5.53%-10.71%-10.71%
90d2+100.00%-10.10%+7.41%-17.51%-17.51%
180d2+0.00%+48.44%+12.39%+36.05%+36.05%
1y2+0.00%+45.37%+0.34%+45.03%+45.03%
2y2+0.00%+112.00%+3.22%+108.79%+108.79%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
XENE · 0 shares · as of May 27, 2021
040,15780,314120,471160,6282021SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2021
2021
FLOW · 4 buys / 7 sellsCOVERAGE · 5 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
XENE
XENON PHARMACEUTICALS INC.
SALE
2,579$18.69$48.2K152,138May 27, 2021Jun 1, 2021View →
XENE
XENON PHARMACEUTICALS INC.
SALE
507$18.88$9.6K124,620May 27, 2021Jun 1, 2021View →
XENE
XENON PHARMACEUTICALS INC.
SALE
3,0860May 27, 2021Jun 1, 2021View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASE
3,086$3.76$11.6K125,127May 27, 2021Jun 1, 2021View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASE
36,008$3.76$135.4K160,628May 27, 2021Jun 1, 2021View →
XENE
XENON PHARMACEUTICALS INC.
SALE
5,911$18.88$111.6K154,717May 27, 2021Jun 1, 2021View →
XENE
XENON PHARMACEUTICALS INC.
SALE
8,485$18.68$158.5K143,653May 27, 2021Jun 1, 2021View →
XENE
XENON PHARMACEUTICALS INC.
SALE
36,0080May 27, 2021Jun 1, 2021View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
10,00010,000Jun 1, 2020Jun 2, 2020View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASE
3,086$3.56$11.0K122,041May 29, 2020Jun 2, 2020View →
XENE
XENON PHARMACEUTICALS INC.
SALE
3,0860May 29, 2020Jun 2, 2020View →
Other insiders · XENE
Loading peer insiders…
About this filer
CIK 0000938801
ROLE
Director
PRIMARY
XENE
COMPANIES
1
ACTIVE SINCE
May 2020
MARKETPEEL · /INSIDER/0000938801DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback